Chiesi USA Inc - Company Profile
Powered by
All the data and insights you need on Chiesi USA Inc in one report.
- Save hours of research time and resources with
our up-to-date Chiesi USA Inc Strategy Report
- Understand Chiesi USA Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Chiesi USA Inc (Chiesi USA) is a subsidiary of Chiesi Farmaceutici SpA, is a pharmaceutical company that develops, researches, produces, and commercializes therapies in cardiovascular, respiratory, neonatology, rare disease, and special care therapeutics. The company's product portfolio comprises of Cardene I.V. (nicardipine hydrochloride); Curosurf (poractant alfa); Zyflo (zileuton), Bethkis (tobramycin), Argatroban injection (Argatroban), Pertzye (pancrelipase), Kengreal (cangrelor), Cleviprex (clevidipine) and Retavase (reteplase). Its product pipeline encompasses drugs in key therapeutic areas of asthma, chronic obstructive pulmonary diseases, cardiovascular diseases, among others. It also offers products to retail pharmacy chains, wholesalers, group purchasing organizations, hospital systems, and specialty pharmacies. Chiesi USA is headquartered in Cary, North Carolina, the US.
Chiesi USA Inc premium industry data and analytics
Products and Services
Products | Brands |
---|---|
Cardene I.V. (nicardipine hydrochloride) | Cardene I.V. |
Curosurf (poractant alfa) | Curosurf |
Pertzye (pancrelipase) | Pertzye |
XYZ | XYZ |
XYZ | XYZ |
XYZ | XYZ |
Competitor Comparison
Key Parameters | Chiesi USA Inc | Eloxx Pharmaceuticals Inc | Genentech USA Inc | Lupin Pharmaceuticals Inc | Novartis Pharmaceuticals Corp |
---|---|---|---|---|---|
Headquarters | United States of America | United States of America | United States of America | United States of America | United States of America |
City | Cary | Watertown | South San Francisco | Baltimore | East Hanover |
State/Province | North Carolina | Massachusetts | California | Maryland | New Jersey |
No. of Employees | - | 18 | 14,000 | - | - |
Entity Type | Private | Public | Private | Private | Private |
Executives
Name | Position | Board | Since | Age |
---|---|---|---|---|
Jon Zwinski | Chief Executive Officer; General Manager | Senior Management | 2021 | - |
Polly Petrino | Vice President - Finance | Senior Management | 2021 | - |
Donna White | Vice President - Contracts and Compliance | Senior Management | 2017 | - |
Richard Smith | Vice President | Senior Management | 2024 | - |
Marc Claussen | Vice President - Business Excellence & Customer Experience | Senior Management | 2023 | - |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer